BIOCRYST PHARMACEUTICALS, INC. Operating Cash Flow
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Operating Cash Flow of $42.55 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- BIOCRYST PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $104.34M, a 152.63% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$61.79M.
- BIOCRYST PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $291.96M.
- BIOCRYST PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $41.62M, a 404.84% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2025 was $347.37M.
- BIOCRYST PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$52.02M.
- BIOCRYST PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$95.14M.
- BIOCRYST PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$161.85M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $104.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $42.55M 10-Q · filed 2026-08-05 | $334.51M derived: sum of 3 quarters · filed 2026-08-05 | $376.13M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$61.79M 10-Q · filed 2026-05-06 | $230.17M derived: sum of 2 quarters · filed 2026-05-06 | $271.79M derived: sum of 3 quarters · filed 2026-05-06 | $313.10M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $291.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $333.58M derived: sum of 2 quarters · filed 2026-02-26 | $374.89M derived: sum of 3 quarters · filed 2026-08-05 | $347.37M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $41.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $82.93M derived: sum of 2 quarters · filed 2026-08-05 | $55.41M 10-Q · filed 2025-11-04 | $50.20M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $41.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $13.79M 10-Q · filed 2026-08-05 | $8.57M derived: sum of 3 quarters · filed 2026-08-05 | $16.82M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | -$27.52M 10-Q · filed 2026-05-06 | -$32.73M derived: sum of 2 quarters · filed 2026-05-06 | -$24.48M derived: sum of 3 quarters · filed 2026-05-06 | -$25.85M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | -$5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.03M derived: sum of 2 quarters · filed 2026-02-26 | $1.66M derived: sum of 3 quarters · filed 2026-02-26 | -$52.02M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $8.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $6.88M derived: sum of 2 quarters · filed 2025-11-04 | -$46.81M 10-Q · filed 2025-11-04 | -$55.73M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$55.05M 10-Q · filed 2025-08-05 | -$63.97M derived: sum of 3 quarters · filed 2026-02-26 | -$83.87M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$53.68M 10-Q · filed 2025-05-06 | -$62.60M derived: sum of 2 quarters · filed 2026-02-26 | -$82.50M derived: sum of 3 quarters · filed 2026-02-26 | -$101.31M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$8.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$28.82M derived: sum of 2 quarters · filed 2026-02-26 | -$47.63M derived: sum of 3 quarters · filed 2026-02-26 | -$95.14M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$19.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$38.71M derived: sum of 2 quarters · filed 2024-11-05 | -$86.22M 10-Q · filed 2024-11-05 | -$110.07M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-06-30 | -$18.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$66.33M 10-Q · filed 2024-08-06 | -$90.17M derived: sum of 3 quarters · filed 2025-02-25 | -$122.62M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-03-31 | -$47.51M 10-Q · filed 2024-05-07 | -$71.36M derived: sum of 2 quarters · filed 2025-02-25 | -$103.81M derived: sum of 3 quarters · filed 2025-02-25 | -$131.56M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2022-12-31 | -$23.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$56.29M derived: sum of 2 quarters · filed 2025-02-25 | -$84.05M derived: sum of 3 quarters · filed 2025-02-25 | -$161.85M 10-K · filed 2025-02-25 | |
| 2022-09-30 | -$32.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$60.20M derived: sum of 2 quarters · filed 2023-11-08 | -$138.00M 10-Q · filed 2023-11-08 | -$170.46M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | -$27.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$105.56M 10-Q · filed 2023-08-07 | -$138.02M derived: sum of 3 quarters · filed 2024-02-27 | -$161.29M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | -$77.80M 10-Q · filed 2023-05-08 | -$110.26M derived: sum of 2 quarters · filed 2024-02-27 | -$133.53M derived: sum of 3 quarters · filed 2024-02-27 | -$158.95M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | -$32.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$55.73M derived: sum of 2 quarters · filed 2024-02-27 | -$81.15M derived: sum of 3 quarters · filed 2024-02-27 | -$142.16M 10-K · filed 2024-02-27 | |
| 2021-09-30 | -$23.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$48.69M derived: sum of 2 quarters · filed 2022-11-04 | -$109.70M 10-Q · filed 2022-11-04 | -$152.23M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | -$25.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$86.42M 10-Q · filed 2022-08-05 | -$128.95M derived: sum of 3 quarters · filed 2023-02-27 | -$167.21M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | -$61.01M 10-Q · filed 2022-05-09 | -$103.54M derived: sum of 2 quarters · filed 2023-02-27 | -$141.80M derived: sum of 3 quarters · filed 2023-02-27 | -$172.84M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | -$42.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$80.79M derived: sum of 2 quarters · filed 2023-02-27 | -$111.83M derived: sum of 3 quarters · filed 2023-02-27 | -$135.11M 10-K · filed 2023-02-27 | -$137.22M 10-K · filed 2021-03-01 |
| 2020-09-30 | -$38.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$69.30M derived: sum of 2 quarters · filed 2021-11-04 | -$92.58M 10-Q · filed 2021-11-04 | -$103.03M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | -$31.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$54.32M 10-Q · filed 2021-08-09 | -$64.77M derived: sum of 3 quarters · filed 2022-02-28 | -$92.41M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$23.28M 10-Q · filed 2021-05-07 | -$33.73M derived: sum of 2 quarters · filed 2022-02-28 | -$61.37M derived: sum of 3 quarters · filed 2022-02-28 | -$85.87M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | -$10.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$38.09M derived: sum of 2 quarters · filed 2022-02-28 | -$62.59M derived: sum of 3 quarters · filed 2022-02-28 | -$89.58M 10-K · filed 2022-02-28 | |
| 2019-09-30 | -$27.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$52.14M derived: sum of 2 quarters · filed 2020-11-06 | -$79.14M 10-Q · filed 2020-11-06 | -$103.12M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | -$24.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$51.50M 10-Q · filed 2020-08-07 | -$75.48M derived: sum of 3 quarters · filed 2021-03-01 | -$110.52M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | -$27.00M 10-Q · filed 2020-05-11 | -$50.98M derived: sum of 2 quarters · filed 2021-03-01 | -$86.02M derived: sum of 3 quarters · filed 2021-03-01 | -$99.91M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | -$23.98M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$59.02M derived: sum of 2 quarters · filed 2021-03-01 | -$72.91M derived: sum of 3 quarters · filed 2021-03-01 | -$92.56M 10-K · filed 2021-03-01 | |
| 2018-09-30 | -$35.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$48.93M derived: sum of 2 quarters · filed 2019-11-08 | -$68.58M 10-Q · filed 2019-11-08 | -$79.10M derived: sum of 4 quarters · filed 2020-03-13 | |
| 2018-06-30 | -$13.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$33.55M 10-Q · filed 2019-08-08 | -$44.07M derived: sum of 3 quarters · filed 2020-03-13 | -$56.50M derived: sum of 4 quarters · filed 2020-03-13 | |
| 2018-03-31 | -$19.65M 10-Q · filed 2019-05-09 | -$30.17M derived: sum of 2 quarters · filed 2020-03-13 | -$42.60M derived: sum of 3 quarters · filed 2020-03-13 | -$52.27M derived: sum of 4 quarters · filed 2020-03-13 | |
| 2017-12-31 | -$10.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$22.95M derived: sum of 2 quarters · filed 2020-03-13 | -$32.62M derived: sum of 3 quarters · filed 2020-03-13 | -$41.14M 10-K · filed 2020-03-13 | |
| 2017-09-30 | -$12.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$22.10M derived: sum of 2 quarters · filed 2018-11-08 | -$30.62M 10-Q · filed 2018-11-08 | -$36.48M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-06-30 | -$9.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$18.19M 10-Q · filed 2018-08-09 | -$24.05M derived: sum of 3 quarters · filed 2019-03-14 | ||
| 2017-03-31 | -$8.53M 10-Q · filed 2018-05-09 | -$14.38M derived: sum of 2 quarters · filed 2019-03-14 | |||
| 2016-12-31 | -$5.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$53.44M 10-K · filed 2019-03-14 | |||
| 2016-09-30 | -$47.58M 10-Q · filed 2017-11-08 | ||||
| 2015-12-31 | -$13.12M 10-K · filed 2018-03-12 | ||||
| 2014-09-30 | -$8.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$15.70M derived: sum of 2 quarters · filed 2014-11-07 | -$24.66M 10-Q · filed 2014-11-07 | -$29.18M derived: sum of 4 quarters · filed 2014-11-07 | |
| 2014-06-30 | -$7.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$16.06M 10-Q · filed 2014-08-08 | -$20.58M derived: sum of 3 quarters · filed 2014-08-08 | -$28.50M derived: sum of 4 quarters · filed 2014-11-07 | |
| 2014-03-31 | -$8.96M 10-Q · filed 2014-05-09 | -$13.47M derived: sum of 2 quarters · filed 2014-05-09 | -$21.40M derived: sum of 3 quarters · filed 2014-11-07 | -$24.29M derived: sum of 4 quarters · filed 2014-11-07 | |
| 2013-12-31 | -$4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | -$12.44M derived: sum of 2 quarters · filed 2014-11-07 | -$15.33M derived: sum of 3 quarters · filed 2014-11-07 | -$26.53M 10-K · filed 2014-03-10 | |
| 2013-09-30 | -$7.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$10.82M derived: sum of 2 quarters · filed 2014-11-07 | -$22.02M 10-Q · filed 2014-11-07 | -$29.05M derived: sum of 4 quarters · filed 2014-11-07 | |
| 2013-06-30 | -$2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$14.09M 10-Q · filed 2014-08-08 | -$21.12M derived: sum of 3 quarters · filed 2014-08-08 | -$32.90M derived: sum of 4 quarters · filed 2014-08-08 | |
| 2013-03-31 | -$11.20M 10-Q · filed 2014-05-09 | -$18.23M derived: sum of 2 quarters · filed 2014-05-09 | -$30.00M derived: sum of 3 quarters · filed 2014-05-09 | -$36.35M derived: sum of 4 quarters · filed 2014-05-09 | |
| 2012-12-31 | -$7.03M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | -$18.81M derived: sum of 2 quarters · filed 2014-03-10 | -$25.15M derived: sum of 3 quarters · filed 2014-03-10 | -$37.40M 10-K · filed 2014-03-10 | |
| 2012-09-30 | -$11.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$18.12M derived: sum of 2 quarters · filed 2013-11-08 | -$30.37M 10-Q · filed 2013-11-08 | -$34.35M derived: sum of 4 quarters · filed 2014-03-10 | |
| 2012-06-30 | -$6.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$18.59M 10-Q · filed 2013-08-08 | -$22.57M derived: sum of 3 quarters · filed 2014-03-10 | -$33.04M derived: sum of 4 quarters · filed 2014-03-10 | |
| 2012-03-31 | -$12.25M 10-Q · filed 2013-05-09 | -$16.23M derived: sum of 2 quarters · filed 2014-03-10 | -$26.70M derived: sum of 3 quarters · filed 2014-03-10 | -$30.17M derived: sum of 4 quarters · filed 2014-03-10 | |
| 2011-12-31 | -$3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | -$14.45M derived: sum of 2 quarters · filed 2014-03-10 | -$17.92M derived: sum of 3 quarters · filed 2014-03-10 | -$32.25M 10-K · filed 2014-03-10 | |
| 2011-09-30 | -$10.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$13.94M derived: sum of 2 quarters · filed 2012-11-08 | -$28.27M 10-Q · filed 2012-11-08 | -$34.09M derived: sum of 4 quarters · filed 2013-03-11 | |
| 2011-06-30 | -$3.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$17.80M 10-Q · filed 2012-08-08 | -$23.62M derived: sum of 3 quarters · filed 2013-03-11 | -$32.85M derived: sum of 4 quarters · filed 2013-03-11 | |
| 2011-03-31 | -$14.33M 10-Q · filed 2012-05-08 | -$20.15M derived: sum of 2 quarters · filed 2013-03-11 | -$29.38M derived: sum of 3 quarters · filed 2013-03-11 | ||
| 2010-12-31 | -$5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | -$15.05M derived: sum of 2 quarters · filed 2013-03-11 | -$28.55M 10-K · filed 2013-03-11 | ||
| 2010-09-30 | -$9.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$22.73M 10-Q · filed 2011-11-03 | |||
| 2010-06-30 | -$13.51M 10-Q · filed 2011-08-04 | ||||
| 2009-12-31 | -$16.22M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |